Series B - Waterstone Pharmaceuticals
Investment Firm
Overview
Waterstone Pharmaceuticals is engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases.
Announced Date
Aug 21, 2012
Funding Type
Series B
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 Acorn Campus Ventures |
 Burrill & Company |
Round Details and Background
Waterstone Pharmaceuticals raised $3392121 on 2012-08-21 in Series B
Waterstone Pharmaceuticals is engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 26, 2012 |  Debt Financing - Waterstone Pharmaceuticals | - | 19.0M | |
| Aug 21, 2012 | Series B - Waterstone Pharmaceuticals | 2 | - | 3.4M |
Recent Activity
There is no recent news or activity for this profile.